Sudeep Pharma uploads Q4FY26 earnings call audio

1 min read     Updated on 23 May 2026, 10:05 AM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Sudeep Pharma has uploaded the audio recording of its earnings call for Q4FY26, held on May 22, 2026, in compliance with Regulation 30 of the SEBI Listing Regulations, 2015. The recording is accessible via the company's official website, while the official transcript is set to be submitted separately to the exchanges.

powered bylight_fuzz_icon
41010172

*this image is generated using AI for illustrative purposes only.

Sudeep Pharma has uploaded the audio recording of its earnings call for the fourth quarter of the fiscal year 2026. The recording corresponds to the proceedings held on May 22, 2026, and is now available for access on the company’s official website.

The disclosure was made in reference to Regulation 30 of the SEBI Listing Regulations, 2015. The company had previously intimated the exchanges regarding the schedule for the earnings call and the investor presentation.

Accessing the Recording

Stakeholders and interested investors can listen to the audio recording directly through the link provided on the Sudeep Pharma website. The specific file, named for the quarter, has been hosted to ensure transparency and broad access to the financial discussions.

Key Details

Event Date Status
Earnings Call Date May 22, 2026 Held
Audio Upload May 22, 2026 Available
Transcript Submission Pending To be submitted

The company confirmed that while the audio is currently available, the official transcript of the earnings call will be submitted to the exchanges separately. This ensures that a written record of the management's commentary and financial analysis is also on the public record.

Historical Stock Returns for Sudeep Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
+3.48%+7.37%+3.23%-9.99%-9.99%-9.99%

What key financial metrics and guidance did Sudeep Pharma's management reveal during the Q4 FY2026 earnings call that could signal future growth trajectory?

How does Sudeep Pharma's Q4 FY2026 performance compare to industry peers, and what does this imply for its competitive positioning in the pharmaceutical sector?

What strategic initiatives or pipeline developments did management discuss that could impact Sudeep Pharma's revenue outlook for FY2027?

Sudeep Pharma to attend investor meets on May 28, June 8

1 min read     Updated on 23 May 2026, 10:00 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Sudeep Pharma Limited announced its participation in two investor conferences in Mumbai on May 28 and June 8, 2026. Officials will meet analysts and institutional investors during the 360 ONE Capital and ICICI Securities events. The company confirmed that only public information will be discussed.

powered bylight_fuzz_icon
41056223

*this image is generated using AI for illustrative purposes only.

Sudeep Pharma Limited has intimated that its officials will participate in upcoming investor conferences scheduled for May 28 and June 8, 2026. The meetings are being held pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Investor Conference Schedule

The company management will engage in one-on-one and group meetings with analysts and institutional investors. The discussions will be based solely on publicly available information, and no unpublished price sensitive information (UPSI) will be shared.

Date Time Nature of Meeting Investor/ Analyst Event Location Mode of Meeting
Thursday, 28 May 2026 09:00 AM IST Onwards 1x1 / Group Meeting 360 ONE Capital (B&K) 16th Annual Investor Conference - TRINITY INDIA 2026 Grand Hyatt, Mumbai Physical
Monday, 08 June 2026 09:00 AM IST Onwards 1x1 / Group Meeting ICICI Securities India Investor Conference India Rising: The Next Chapter Grand Hyattt, Mumbai Physical

Conference Details

The first event is the 360 ONE Capital (B&K) 16th Annual Investor Conference, titled TRINITY INDIA 2026, set to take place on May 28. Following this, the company will attend the ICICI Securities India Investor Conference, themed "India Rising: The Next Chapter," on June 8. Both events will be conducted physically at the Grand Hyatt in Mumbai.

The company noted that changes to the schedule may occur due to exigencies on the part of the host or the company. Dimple Mehta, Company Secretary & Compliance Officer, signed the intimation on May 23, 2026.

Historical Stock Returns for Sudeep Pharma

1 Day5 Days1 Month6 Months1 Year5 Years
+3.48%+7.37%+3.23%-9.99%-9.99%-9.99%

What strategic growth initiatives or pipeline developments might Sudeep Pharma's management highlight to institutional investors at these conferences?

How could increased visibility with institutional investors at high-profile events like ICICI Securities and 360 ONE Capital conferences impact Sudeep Pharma's stock liquidity and analyst coverage?

Are there any upcoming product launches, regulatory approvals, or expansion plans that investors should watch for following these investor engagements?

More News on Sudeep Pharma

1 Year Returns:-9.99%